NGO Innovarte participates in WHO’s Intergovernmental Negotiating Body (INB) for the...
World Health Organization (WHO) countries are working together on a new global instrument to better protect individuals, communities, and countries from future pandemics.
In the framework of...
Opinion Article: Time is running out for WHO Pandemic Preparedness Treaty...
We invite you to read the opinion article "Time is running out: WHO Pandemic Preparedness Treaty negotiations" by Director Luis Villarroel, published in the newspaper...
Innovarte NGO meets with Senator Ximena Rincon
On June 15, 2023, Innovarte together with the advisors Thomas Vinje and Michael Jacobs, visited the offices of Senator Ximena Rincon to present relevant...
64th General Assembly of the World Intellectual Property Organization (WIPO)
Today, July 7, 2023, Innovarte NGO made the first intervention at the 64th General Assembly of WIPO through its Director Luis Villarroel, highlighting the...
Fourth Annual Conference of the Max Planck Institute’s Smart IP event...
During the week of April 24th-28th of this year, the Fourth Annual Conference of the Smart IP event for Latin America was held in São Paulo, Brazil.
Our...
The importance of legalizing Text and Data Mining as a research...
Versión en español disponible en Diario El Mostrador
In Chile, the scenario is critical. Although we are members of the Organization for Economic Cooperation and...
WE CONTINUE THE CAMPAIGN FOR PFIZER TO ALLOW THE DISTRIBUTION OF...
Paxlovid helps prevent #PERSISTENTCOVID and reduces hospitalization of older adults by 85%. But the pharmaceutical company does not allow the distribution of generics. Let...
NGO INNOVARTE AND AIS PERU SEND LETTER TO THE MINISTER OF...
On December 29th, 2022, AIS Peru and NGO INNOVARTE sent a letter to Dr. Rosa Gutierrez Palomino, Minister of Health of Peru, highlighting the...
WE CONTINUE CAMPAIGNING FOR PFIZER TO ALLOW DISTRIBUTION OF GENERIC DRUGS
NGO Innovarte (Chile) AIS (Peru) and other non-profit organizations, we request Pfizer to end its monopoly on the antiviral drug Paxlovid™ and allow the...
